Federal Register of Legislation - Australian Government

Primary content

PB 112 of 2009 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide conditions for payments in respect of supply of pharmaceutical benefits by approved pharmacists and medical practitioners.
Administered by: Health
Registered 20 Nov 2009
Tabling HistoryDate
Tabled HR23-Nov-2009
Tabled Senate23-Nov-2009
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 112 of 2009

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 12 November 2009

 

 

 

 

 

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing


Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 December 2009.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.



Schedule 1            Amendments

 

[1]     Schedule 4, item dealing with Calcipotriol

omit from the column headed “Form (strength, type, size, etc.)”:

 

Ointment 50 micrograms per g, 30 g

[2]     Schedule 4, after item dealing with Calcipotriol

insert in the columns in the order indicated:

Calcipotriol with betamethasone

Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g

[3]     Schedule 4, after item dealing with Pimecrolimus

insert in the columns in the order indicated:

Polyethylene glycol 400

Eye drops 2.5 mg per mL, 15 mL